SG Americas Securities LLC Sells 12,346 Shares of Stryker Corporation (SYK)

SG Americas Securities LLC reduced its position in shares of Stryker Corporation (NYSE:SYK) by 66.0% during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 6,365 shares of the medical technology company’s stock after selling 12,346 shares during the period. SG Americas Securities LLC’s holdings in Stryker were worth $904,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also recently bought and sold shares of the company. Vanguard Group Inc. lifted its position in shares of Stryker by 2.8% during the second quarter. Vanguard Group Inc. now owns 24,078,709 shares of the medical technology company’s stock worth $3,341,643,000 after purchasing an additional 657,656 shares in the last quarter. BlackRock Inc. lifted its position in shares of Stryker by 5.2% during the second quarter. BlackRock Inc. now owns 23,115,853 shares of the medical technology company’s stock worth $3,208,017,000 after purchasing an additional 1,139,082 shares in the last quarter. Jensen Investment Management Inc. lifted its position in shares of Stryker by 11.3% during the third quarter. Jensen Investment Management Inc. now owns 2,472,476 shares of the medical technology company’s stock worth $351,141,000 after purchasing an additional 251,685 shares in the last quarter. Legal & General Group Plc lifted its position in shares of Stryker by 4.7% during the second quarter. Legal & General Group Plc now owns 1,756,429 shares of the medical technology company’s stock worth $243,769,000 after purchasing an additional 78,126 shares in the last quarter. Finally, Swiss National Bank lifted its position in shares of Stryker by 1.0% during the third quarter. Swiss National Bank now owns 1,711,871 shares of the medical technology company’s stock worth $243,120,000 after purchasing an additional 17,300 shares in the last quarter. 74.97% of the stock is currently owned by institutional investors and hedge funds.

Stryker Corporation (NYSE SYK) traded down $0.13 on Monday, reaching $155.87. 1,263,800 shares of the company traded hands, compared to its average volume of 1,181,647. The firm has a market capitalization of $58,332.41, a PE ratio of 24.70, a PEG ratio of 2.45 and a beta of 0.78. The company has a quick ratio of 1.61, a current ratio of 2.37 and a debt-to-equity ratio of 0.63. Stryker Corporation has a 1 year low of $111.22 and a 1 year high of $160.62.

Stryker (NYSE:SYK) last released its earnings results on Thursday, October 26th. The medical technology company reported $1.52 earnings per share for the quarter, beating the consensus estimate of $1.50 by $0.02. Stryker had a net margin of 14.67% and a return on equity of 24.11%. The firm had revenue of $3.01 billion during the quarter, compared to analyst estimates of $2.97 billion. During the same quarter in the previous year, the firm earned $1.39 earnings per share. The firm’s revenue for the quarter was up 6.1% compared to the same quarter last year. sell-side analysts predict that Stryker Corporation will post 6.47 earnings per share for the current year.

In other Stryker news, insider Lonny J. Carpenter sold 5,000 shares of the business’s stock in a transaction on Friday, November 3rd. The shares were sold at an average price of $155.34, for a total transaction of $776,700.00. Following the completion of the sale, the insider now owns 83,207 shares in the company, valued at $12,925,375.38. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. 7.40% of the stock is owned by insiders.

A number of research analysts have recently commented on the stock. Zacks Investment Research cut shares of Stryker from a “buy” rating to a “hold” rating in a research report on Thursday, August 17th. BidaskClub raised shares of Stryker from a “hold” rating to a “buy” rating in a research report on Thursday, August 17th. Argus reissued a “buy” rating and set a $160.00 target price on shares of Stryker in a research report on Tuesday, August 29th. Cowen set a $160.00 target price on shares of Stryker and gave the stock a “buy” rating in a research report on Friday, October 6th. Finally, Robert W. Baird raised shares of Stryker from a “neutral” rating to an “outperform” rating in a report on Friday, November 24th. Two analysts have rated the stock with a sell rating, ten have given a hold rating and thirteen have issued a buy rating to the company. Stryker has a consensus rating of “Hold” and a consensus price target of $152.10.

ILLEGAL ACTIVITY WARNING: “SG Americas Securities LLC Sells 12,346 Shares of Stryker Corporation (SYK)” was reported by Week Herald and is the property of of Week Herald. If you are reading this story on another website, it was illegally copied and reposted in violation of international trademark and copyright laws. The correct version of this story can be viewed at https://weekherald.com/2017/12/04/sg-americas-securities-llc-sells-12346-shares-of-stryker-corporation-syk.html.

Stryker Company Profile

Stryker Corporation is a medical technology company. The Company offers a range of medical technologies, including orthopedic, medical and surgical, and neurotechnology and spine products. The Company’s segments include Orthopaedics; MedSurg; Neurotechnology and Spine, and Corporate and Other. The Orthopaedics segment includes reconstructive (hip and knee) and trauma implant systems and other related products.

Want to see what other hedge funds are holding SYK? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Stryker Corporation (NYSE:SYK).

Institutional Ownership by Quarter for Stryker (NYSE:SYK)

Receive News & Ratings for Stryker Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stryker Corporation and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply